Healthcare provider profile · identity verified

Jay Tyler Rohde, MD

Internal Medicine · WASHINGTON, IL · NPI 1457671745

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	444	137
Amlodipine Besylate	Amlodipine Besylate	319	84
Levothyroxine Sodium	Levothyroxine Sodium	312	82
Lisinopril	Lisinopril	287	78
Losartan Potassium	Losartan Potassium	266	78
Gabapentin	Gabapentin	192	52
Omeprazole	Omeprazole	188	57
Metformin Hcl	Metformin Hcl	185	49
Simvastatin	Simvastatin	182	53
Hydrochlorothiazide	Hydrochlorothiazide	150	40
Furosemide	Furosemide	143	37
Metoprolol Succinate	Metoprolol Succinate	137	40
Rosuvastatin Calcium	Rosuvastatin Calcium	122	33
Pravastatin Sodium	Pravastatin Sodium	111	29
Sertraline Hcl	Sertraline Hcl	106	35
Pregabalin	Pregabalin	105	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	102	22
Montelukast Sodium	Montelukast Sodium	100	27
Fluoxetine Hcl	Fluoxetine Hcl	94	23
Glipizide Er	Glipizide	93	24
Allopurinol	Allopurinol	89	24
Hydroxyzine Hcl	Hydroxyzine Hcl	84	22
Tamsulosin Hcl	Tamsulosin Hcl	81	31
Jardiance	Empagliflozin	79	22
Prednisone	Prednisone	75	62
Donepezil Hcl	Donepezil Hcl	74	20
Citalopram Hbr	Citalopram Hydrobromide	69	20
Ozempic	Semaglutide	69	12
Metoprolol Tartrate	Metoprolol Tartrate	65	22
Pantoprazole Sodium	Pantoprazole Sodium	65	21
Buspirone Hcl	Buspirone Hcl	64	19
Trazodone Hcl	Trazodone Hcl	62	22
Carvedilol	Carvedilol	60	17
Zolpidem Tartrate	Zolpidem Tartrate	60	12
Albuterol Sulfate Hfa	Albuterol Sulfate	59	26
Duloxetine Hcl	Duloxetine Hcl	59	13
Glimepiride	Glimepiride	59	15
Meloxicam	Meloxicam	59	21
Clopidogrel	Clopidogrel Bisulfate	58	21
Potassium Chloride	Potassium Chloride	57	19
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	18
Fluticasone Propionate	Fluticasone Propionate	55	22
Tramadol Hcl	Tramadol Hcl	55	19
Ezetimibe	Ezetimibe	53	19
Metformin Hcl Er	Metformin Hcl	53	13
Spironolactone	Spironolactone	53	14
Breo Ellipta	Fluticasone/Vilanterol	50	11
Alprazolam	Alprazolam	47	suppressed
Famotidine	Famotidine	47	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	45	14
Atenolol	Atenolol	43	11
Eliquis	Apixaban	43	12
Ramipril	Ramipril	41	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	41	12
Escitalopram Oxalate	Escitalopram Oxalate	40	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	13
Lorazepam	Lorazepam	37	16
Ropinirole Hcl	Ropinirole Hcl	36	suppressed
Fenofibrate	Fenofibrate	34	suppressed
Ketoconazole	Ketoconazole	33	16
Cephalexin	Cephalexin	32	27
Glipizide	Glipizide	32	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Alendronate Sodium	Alendronate Sodium	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Novolin N	Insulin Nph Human Isophane	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	24	suppressed
Tizanidine Hcl	Tizanidine Hcl	24	11
Doxycycline Hyclate	Doxycycline Hyclate	23	19
Sucralfate	Sucralfate	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Meclizine Hcl	Meclizine Hcl	21	11
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	20	suppressed
Propranolol Hcl	Propranolol Hcl	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	19	suppressed
Baclofen	Baclofen	18	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Chlorthalidone	Chlorthalidone	18	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	14
Fluconazole	Fluconazole	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Risperidone	Risperidone	17	suppressed
Mounjaro	Tirzepatide	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Clindamycin Hcl	Clindamycin Hcl	15	11
Finasteride	Finasteride	15	suppressed
Hydrocortisone	Hydrocortisone	15	suppressed
Mometasone Furoate	Mometasone Furoate	15	suppressed
Naproxen	Naproxen	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Bumetanide	Bumetanide	14	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Lamotrigine	Lamotrigine	14	suppressed
Nabumetone	Nabumetone	14	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	14	14
Diazepam	Diazepam	13	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Azithromycin	Azithromycin	12	11
Bupropion Hcl	Bupropion Hcl	12	suppressed
Klor-Con M20	Potassium Chloride	12	suppressed
Midodrine Hcl	Midodrine Hcl	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Sildenafil Citrate	Sildenafil Citrate	12	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	11	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Morphine Sulfate Er	Morphine Sulfate	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Praluent Pen	Alirocumab	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error